Nivolumab Does Not Improve Post-ICI Therapy Progression-Free Survival in Advanced Renal Cell Carcinoma
1. No significant difference was seen regarding progression-free survival between the...
Read More
chronic-disease
Glucagon-like peptide 1 receptor agonists may decrease rates of inflammatory bowel disease flares
1. The use of glucagon-like peptide 1 (GLP-1) agonists in patients with inflammatory bowel disease...
Read More
Pembrolizumab with chemoradiotherapy improves survival in locally advanced cervical cancer
1. 36-month overall survival was significantly greater in the pembrolizumab-chemoradiotherapy...
Read More
Glucagon-like peptide-1 receptor agonists may impact outcomes of endoscopy
1. The use of glucagon-like peptide 1 (GLP-1) receptor agonists in adults with type 2 diabetes...
Read MoreHigh levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver
1. Increased levels of hypersensitive C-reactive protein was associated with increased risk of non-alcoholic fatty liver disease among non-obese individuals. Evidence Rating Level: 3 (Average) Non-alcoholic fatty liver disease...
Read More
Timely diagnosis of migraine may prevent future emergency department
1. Half of patients visiting the emergency department for acute migraine could have been diagnosed...
Read More
Males With Lupus Nephritis Have Higher All-Cause Mortality & Infection-Related Death
1. Males with lupus nephritis had higher all-cause mortality and proportion of infection-related...
Read More
Mineralocorticoid receptor antagonists reduce hospitalizations in patients with heart failure with preserved or mildly reduced ejection fraction
1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients...
Read More
Perioperative Pembrolizumab Improves Survival in Resectable Early-Stage Non-Small Cell Lung Cancer
1. 36-month overall survival and median event-free survival were significantly greater in the...
Read More
High cardiovascular disease mortality among Native Hawaiian and Pacific Islander adults
1. In this cross-sectional study, researchers found that Native Hawaiian and Pacific Islander...
Read More
Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF or F/TAF
1. In this randomized controlled trial, among adolescent girls and young women, it was found that...
Read More
Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy
1. In a cohort of individuals with invasive ductal carcinoma (IDC) that underwent...
Read More
ANGPLT3 interfering RNA therapy reduces triglyceride levels in mixed hyperlipidemia
1. Zodasiran, an RNA interference (RNAi) therapy targeting angiopoietin-like 3 (ANGPTL3), resulted...
Read More
Probiotic and vitamin D co-supplementation not associated with improved outcomes in patients with migraine headache
1. In a randomized triple-blinded controlled trial, probiotic and vitamin D supplementation did...
Read More
Using the DemRisk prediction model to indentify individuals at high risk for dementia in primary care
1. Predicting dementia in primary care settings for a 60-79 year old cohort should include age,...
Read More
Combination of doxorubicin-trabectedin with trabectedin improves leiomyosarcoma outcomes
1. In patients with advanced leiomyosarcoma, a regimen of doxorubicin-trabectedin was superior to...
Read More
Pomalidomide effective in reducing epistaxis in hereditary hemorrhagic telangiectasia
1. Among patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide significantly...
Read More
Tirzepatide reduces obstructive sleep apnea symptoms and associated risks
1. In this randomized controlled trial, in patients with both moderate-severe obstructive sleep...
Read More
DaxibotulinumtoxinA trial for injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury
1. DaxibotulinumtoxinA-lanm 500U showed the greatest reduction in MAS scores in patients suffering...
Read More
Fidanacogene elaparovovec may reduce bleeding in men with hemophilia B
1. In this randomized controlled trial, fidanacogene elaparovovec therapy significantly reduced...
Read More